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Does Canada's publicly funded, single payer health care system deliver better health outcomes and
distribute health resources more equitably than the multi-payer heavily private U.S. system? We show
that the efficacy of health care systems cannot be usefully evaluated by comparisons of infant mortality
and life expectancy. We analyze several alternative measures of health status using JCUSH (The Joint
Canada/U.S. Survey of Health) and other surveys. We find a somewhat higher incidence of chronic
health conditions in the U.S. than in Canada but somewhat greater U.S. access to treatment for these
conditions. Moreover, a significantly higher percentage of U.S. women and men are screened for major
forms of cancer. Although health status, measured in various ways is similar in both countries, mortality/incidence
ratios for various cancers tend to be higher in Canada.  The need to ration resources in Canada, where
care is delivered "free", ultimately leads to long waits. In the U.S., costs are more often a source of
unmet needs. We also find that Canada has no more abolished the tendency for health status to improve
with income than have other countries. Indeed, the health-income gradient is slightly steeper in Canada
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      The ongoing debate over how to cover the uninsured has generated interest and 
support for a nationalized single payer system as an alternative to our mainly private 
multi-payer system.
1 The Canadian single payer system is often upheld as an example of 
the improvements in health outcomes, savings in costs, and more equitable distribution of 
resources that could be achieved with a system change. The U.S. health care system is 
often critiqued by noting that health expenditures in the U.S. are the highest among the 
OECD countries---twice as high on a per capita basis as Canada’s. Yet, as measured by 
two popular indicators of health status— infant mortality and life expectancy ---the U.S. 
lags behind Canada and many other OECD countries.  However, both infant mortality 
and life expectancy are poor measures of the efficacy of a health care system because 
they are influenced by many factors that are unrelated to the quality and accessibility of 
medical care.  
      In this paper we focus on three questions: (1) What does the evidence show 
regarding differences in health status that can be attributed to the two systems?; (2) How 
does access to needed health care resources compare between the two countries?; and (3) 
Is inequality in access to resources different in the two countries? In other words, what do 
the data show about differences in the health/income gradient between the two countries? 
    In this paper we address these issues using a recent data set from the Joint Canada/ 
U.S. Survey of Health (JCUSH). The survey has the unique feature of being a single 
survey, designed and conducted jointly by Statistics Canada and the U.S. National Center 
for Health Statistics. Representative samples of U.S. and Canadian residents were asked 
the same set of questions under similar conditions. The survey provides information on a 
wide array of issues related to health status, access to health resources and personal 
demographic, behavioral and economic characteristics.  
 We supplement our findings from JCUSH with analysis of data from other Canadian and 
U.S. surveys and other national and international sources. 
                                                 
1 For example, Physicians for A National Health Program, an organization of 14,000 members, strongly 
advocates conversion to a single payer system.  
1   Briefly, our findings are: No significant differences are evident in the four health 
status indicators available in the JCUSH data; A somewhat greater incidence of chronic 
health conditions in the U.S. combined with evidence of greater access to health 
treatments in the U.S.; greater access in the U.S. to important health care resources and 
no evidence that the income/health gradient is any different between the U.S. and 
Canada. Finally, on two questions asked about satisfaction with health services and the 
ranking of the quality of services recently received, more U.S. residents than Canadians 
answered fully satisfied and excellent.   
   We start by reviewing background information on the Canadian system. We then  
examine traditional measures of a nation’s health status: life expectancy and mortality 
before turning to our analysis of health status differences as shown in JCUSH and other 
surveys. Resources are bound to affect the quality of care and we briefly compare those 
in Canada and the U.S. Finally we analyze and compare the effect of income on health 
status in the two countries. 
Background on the Canadian Health System        
    Since the late 1960s Canada essentially has had a universal health insurance system 
covering all services provided by physicians and hospitals. To implement universal 
coverage the federal and provincial governments took over full funding of both hospital 
and physician services, setting physician fees and hospital budgets. During the 70’s 
physicians, dissatisfied with the official fee amounts, chose to work outside the system 
and bill patients at higher amounts. But with the  passage of the Canadian Health Act of 
1984  Canada outlawed extra billing and became a rigid one-tier system which restricted 
the provision of any “core” services outside the public’s so-called “Medicare” system 
(Irvine, Ferguson and Cackett).   
   All care is “free” for insured services —those provided by physicians and hospitals. 
No premiums, deductibles or co-payments are imposed. (Other services such as dental 
care and prescription drugs must be paid for either through private insurance or out-of-
pocket.) When no one is faced with any charge for services, demand is unrestrained and 
costs surge. During the 90’s the federal government cut back the block amounts given to 
2the provinces. It is not surprising that shortages developed and explicit rationing became 
widespread in Canada. 
2  
         The shortages and queues that resulted became an increasingly sore subject in 
Canada. The condition for shortages was enhanced because of the provision in the 1984 
Act that decreed that any service that the single payer provides, no matter how much in 
short supply it may be, cannot be privately insured or produced and sold in Canada. 
Relief came, however, in 2005 when the 1984 Act was struck down as unconstitutional 
by Canada’s highest court {Chaoulli v.Quebec (Attorney General), 2005, IS.C.R. 791, 
2005 SCC 35}. A slim 4/3 majority ruled that the government’s argument—that allowing 
a private sector, would undermine their public system—was not supported by the actual 
experience of other countries (U.K., France and Germany) that had converted from single 
payer to dual systems.    
 Some legal experts have concluded that the Chaoulli decision does not require the 
government to give up its single payer system as long as it keeps waiting times within a 
reasonable amount, especially for serious cases. But in practice the decision seems to 
have led to a large increase in private facilities providing core services, with the 
expectation that the government will not bring them to court given the Chaoulli decision 
(Krauss, NY Times, 2006). To many observers Canada now is on its way to becoming a 
two-tier system. 
     Private-sector spending on health has been growing faster than public spending and 
now makes up a little more than 30% of total health expenditures. Canada spends far less 
of its GDP on health expenditures than the United States (10.4%in 2005 compared to 
16%in the U.S.). Public funding of health expenditures has grown in the U.S. and now 
pays for more than 45 % of the nation’s health bill. 
Two Traditional Measures of System Performance and Their Drawbacks 
         Life expectancy and infant mortality are the two measures most frequently cited as 
evidence of the superiority of the Canadian system. of medical care. Current data show 
that life expectancy at birth in the U.S. is 80.1 years for women and 74.8 years for men, 
more than 2 years below Canada’s levels of 82.4 and 77.4 (Table1). Similarly, infant 
                                                 
2 Provincial governments develop fee schedules and set up physician funding pools. If a pool goes over 
budget, “claw-back clauses”  are enforced to ratchet down pay  or doctors may be urged to close for a few 
days. Hospitals meet cost cutting by closing down hospital beds. See MacKenzie,1999. 
3mortality in the U.S. is 6.8 (deaths per 1000 live births) and 5.3 in Canada. But as noted 
above, both of these measures are influenced by many factors that are unrelated to the 
quality and accessibility of medical care. We discuss them briefly in turn. 
         It is well established that infant mortality is strongly linked to low birth weight and 
to preterm births. Preterm births accounted for 36.5% of all infant deaths in the U.S. in 
2004 according to the Center for Disease Control (CDC, 1999-2004). The preterm-related 
infant mortality rate is particularly high for non-Hispanic black mothers---3.5 times 
higher than the rate for non-Hispanic white mothers. This obviously is an important 
factor underlying the huge gap in infant mortality   between blacks and whites in the U.S. 
as shown in table 1. 
       It has long been known that babies born to teenage mothers are at particularly high 
risk of infant mortality due to their high prevalence of low birth weight.  The teenage 
birth rate in the U.S., despite a substantial decline since the early 1990s is the highest 
among comparable countries (United Nations Statistics Division, 2004).  In 2004, the 
teenage birth rate was 41.4 (per 1000 girls 15-19) and that was 2.8 times the rate in 
Canada and 7 times the rates in Japan and Sweden (which have the lowest infant 
mortality rates). Within the U.S. the infant mortality rate, the pre-term related infant 
mortality rate and the teen birth rate are considerably higher for blacks than for whites.
3  
The relatively high percentage of births to teenage mothers in the U.S. and the 
accompanying high rates of infant deaths due to pre-term and low-birth weight births 
surely contribute to the higher U.S. infant mortality rate.  
       Evidence that these factors can explain the infant mortality differential between the 
U.S. and Canada is shown in Table 2 which is based on results of a study by Kramer et. 
al. investigating the decline in infant mortality in the U.S. Canada and other countries. As 
a by-product, the findings provide data on the distribution of births by birth weight in 
Canada and the U.S. and the birth-weight specific infant  mortality rates in each country. 
The data for 1997 (1995-97 in Canada) are displayed in Table 2 and show that the U.S. 
has disproportionately more low weight births than Canada.  For example in the U.S. 
1.4% of births were under 1500 grams compared to 0.9% in Canada. However, within 
                                                 
3 In 2004 the infant mortality rate of black non-Hispanic mothers was 13.6 compared to 5.7 for white non-
Hispanic mothers. About 35% was preterm- related for blacks; 32% for whites. The teenage birth rate in the 
same year was 60 for blacks and 27 for white non-Hispanics.   
4birth weight specific categories, mortality rates in the U.S. were generally the same as in 
Canada. In fact, our calculations indicate that  if in Canada the distribution of births by 
birth weight was the same as in the U.S. their infant mortality rate would rise to 7.06 
from the observed level of  5.5. Similarly if births in the U.S. had the same distribution 
by birth-weight as Canadian births, the U.S. infant mortality rate would have been 5.401 
instead of 6.85. 
     Clearly a multitude of behaviors unrelated to the health care system such as substance 
abuse, smoking and obesity as well as low education and cultural factors are related to the 
low birth weight and preterm births that underlie the infant death syndrome (Corman and 
Grossman, 1985; 1987; Joyce, Racine, McCalla and Wehbeh,  1995; Joyce and 
Grossman, 1990; Kestner, Joyce and Wehbeh,, 1996). It has proven difficult for public 
efforts to improve birth outcomes for low socioeconomic groups simply by reducing 
financial barriers to prenatal care. Improvement in access to health care for low income 
women through extension of Medicaid seems to have increased prenatal care but failed to 
reduce the gap in birth outcomes for poor and non-poor women (Dubay, Joyce, Kaestner 
and Dubay 2001; Currie and Gruber,1996).  
       Life expectancy shares similar problems as a measure of a country’s quality of health 
care. It is influenced by infant mortality and at older ages and does not delineate between 
causes of death susceptible to improved medical treatment ad those that are not (deaths 
from homicide, auto and other accidents). As shown in Table 3, the U.S. leads the 
advanced countries in obesity.  The percent of the female  population in the U.S. that is 
obese is 33.2% and in Canada it is 19.0%, and similar differentials prevail for the men. It 
is noteworthy that in Japan the percent of women who are obese is only 3.2% (men 2.8%) 
and Japan also has the greatest longevity.  Clearly the large differential between the U.S. 
and Canada in obesity accounts for some of their differential in mortality and therefore in 
life expectancy. 
    Table 4 shows the differences between Canada and the U.S. in the causes of mortality 
at different age groups.  Although the overall mortality rate is higher in the U.S. at all age 
groups, the importance non-disease related factors (accidents and homicides) is much 
greater in the U.S.  For men accidents and homicides account for 84% of the gap in  
mortality rates at age group 20-24.  This percentage declines as age increases, but still 
5accounts for close to 30% of the gap at ages 40-44.  At older ages diseases of the heart 
are the primary causes of the gap.  Although the health system can surely play a role, 
diseases of the heart are also influenced by factors like obesity, which contributes to high 
blood pressue, diabetes and other diseases.   
 
Other Measures of Health Status and of  Resource Availability    
   Our analysis of the well known differentials in life expectancy and infant mortality 
suggests that the differentials in these measures of health status (especially infant 
mortality) are not likely to be due to health care system differences between Canada and 
the U.S. We continue our search for evidence of health outcome differentials that can be 
attributed to the effectiveness of the two systems. We utilize the various measures of 
health status available in the JCUSH data as well as in other data sources and we examine 
other indicators of health care services and resources including the waiting times that 
have been sore spots in characterizing the Canadian system. The indicators chosen 
include some of those on the OECD’s list of useful indicators for measuring system 
performance. 
        JCUSH--the Joint Canada/U.S. Survey of Health—was conducted by means of a 
telephone survey of residents of the U.S. and Canada aged 18 and older living in private 
dwellings with telephones. The data were collected during the period November 2002-
March 2003. Interviewers were trained and the survey was administered in English or 
Spanish to Americans and in English or French to Canadians as need dictated. The final 
samples include 3,505 Canadians and 5,183 from the U.S. The US samples were 
stratified by four regions; the Canadian sample by province. Appendix Table A-1 
presents the weighted characteristics of the samples for the two countries used in our 
analysis.                    
           Alternative Health Status Measures 
 Table 5 presents a subjective measure of health status that reflects how individuals rate 
their overall level of health: poor, fair, good, very good and excellent. This is a widely 
used measure in health research. But it has two drawbacks for the purpose of comparing 
the relative efficacy of our two health care systems. One is that it is so broad that it surely 
reflects many factors other than the efficacy of the health care systems. The other is the 
6purely subjective nature of the measure. If the frame of reference influencing the concept 
of good health differs significantly between two countries it may not useful for answering 
the question whether one population is healthier than the other. Given that Canada and 
the U.S. are so close geographically and similar culturally in many ways, this may not be 
a serious problem. In Table 5 we control for two obvious non-system factors that affect 
health status—age and race. We also present results estimated from other major surveys 
of health status in the U.S. and Canada which ask the same question.  
  The results in Table 5 show either no difference in self-perceived health status or a 
slight indication of a higher percentage reporting excellent health in the U.S. It is 
reassuring for the validity of the measure that the older population (ages 65years or more) 
indicates poorer health in both countries. Results from the other surveys –The National 
Health Interview Survey(NHIS) and the U.S. Medical Expenditures Panel Survey 
(MEPS) for the U.S. and the Canadian Community Health Survey (CCHS) for Canada 
are based on much larger sample than the JCUSH data but show very similar results. 
These results are obviously not hard evidence that the quality of health care is the same in 
both countries. More detailed and objective measures of health status must be sought. 
     Table 6 shows three more indicators of health status (all from JCUSH) that are more 
objective, but remain subject to many factors other than the efficacy of the health care 
system. The first measure is the individual’s score on the Health Utility Index (HUI). The 
index, based on the Comprehensive Health Status Measurement System(CHSMS) 
developed at McMaster University, provides a description of an individual’s overall 
functional health based on eight attributes—vision, hearing, speech, mobility (ability to 
get around), dexterity of hands and fingers, memory and thinking, emotion, and pain and 
discomfort. The HUI maps the responses into a scale ranging from negative to 1 (where 
one means perfect health and negative means worse than death). The HUI sequence of 
questions was administered to all respondents. The second measure refers to the 
probability of a major depression in the last year based on a set of questions from the 
Composite International Diagnostic Interview. The last measure is a response to a 
question whether the respondent has pain that prevents some or most activities. 
      The comparisons are shown by age and by race. We use the 65+ age break here and 
throughout the paper because Medicare provides near universal coverage for that age 
7group in the U.S., a factor that might change the relative standing of the countries when 
compared with results for the younger respondents. We show separate results for whites  
because non-whites are a larger proportion of the population in the U.S.(for 18-64 group 
26% for US and 19% for Canada);  the composition of the non-white group differs by 
country—predominantly black in the U.S., but Asian in Canada; and racial differences in 
health outcomes may differ in the two countries. 
       For the 18-64 year old age group the results show no significant difference on any 
of the three indicators especially when the comparison is restricted to whites only.  
The depression index shows a 0.7 percentage point higher probability of depression   
Differences are minimal for the other indicators. For the older group the differentials  
between the U.S. and Canada are about the same as for the younger group. But again 
we note that in comparison with the younger group the older group shows generally 
weaker health based on the lower HUI and the higher level of reported pain. The older 
group also shows a lower level of the probability of depression, which is consistent with 
general psychiatric data that shows that serious mental disorders are more likely to begin 
at younger ages with recovery accompanying the aging process.  
        What can be concluded from this type of data? Seemingly the results suggest that 
if there is a difference in health status it is not large enough to be noticed by the 
population or to generate differences in the other three indices that are based on more 
objective criteria. But the results still cannot tell us whether the health systems are 
equally efficient.  
     Table 7A (for the younger population) and 7B (for those ages 65+) contain measures 
related to the incidence of significant chronic health conditions. Such  health status 
indicators are more specific and are less subjective than overall self reported health 
status. However, like our more subjective measures, they are still influenced by 
socioeconomic status, life styles and genetic factors. But they are likely to be responsive 
to improvement through medical treatment. Table 7A shows that for the first five 
conditions, Canada has a lower incidence in all categories, but the difference is rather 
small except for high blood pressure.  For the last three conditions that relate to the 
functioning of the heart, the two countries are nearly the same. The tables also show the 
percentage of those currently with the condition who are receiving treatment for it.  On 
8this indicator of access to care the U.S. generally performs better with respect to the 
treatment of all conditions except that of asthma.  
   As expected, the incidence of the specified conditions is greater for the over 65 group 
than for the younger group. The percent getting treatment also increases. For the older 
group, the U.S. shows significantly higher incidences of heart disease and coronary heart 
disease and significantly lower incidence of angina, while for those under 65 there is little 
difference between the countries in the much lower incidence figures for these three 
conditions. However, due to sample size limitations the results for the older group are 
less reliable. 
  In sum the message of Tables 7A and 7B is that the incidence of important chronic 
conditions is somewhat higher in the U.S., especially for those that are not heart related, 
while the utilization of treatment for these conditions is somewhat greater in the U.S. We 
next turn to JCUSH and other data sources to investigate the availability of certain key 
health care services in the two countries. 
                  Resource Availability 
     Table 8 shows utilization rates of preventive care services by Canadians and 
Americans. We look at mammography,  PAP Smears and colonoscopy or sigmoidoscopy 
(CorS) for women,  and the incidence of PSA testing and (CorS) for men in the two 
countries for relevant age groups. The table shows first, for each age group, the percent of 
women who at the time of the survey said they had ever had a mammogram or PAP 
smear. The table then distributes this same sub-group by how recently they had their last 
mammogram or PAP smear, but using the total number of women in the age group in the 
denominator. (The percent having the procedure more than 5 years ago is not shown.)  
The table clearly shows that these two significant cancer screening health services are 
used significantly less in Canada than in the U.S., especially when the percentages who 
said they had been screened quite recently are compared.  Given the significance of these 
treatments for preventing mortality due to breast and cervical cancer these differentials 
have to loom large in any comparison between the two countries. The difference in PSA 
testing (for prostate cancer) is also very large as is the difference in (CorS).  Again given 
the importance of these two screening devices (especially colonoscopies for colon 
9cancer) these have to be considered as potentially affecting the health outcomes produced 
by Canada.  
       Table 9 looks at the mental health status of the populations of the two countries, 
focusing on depression and the type of professional help obtained to treat it.  The index 
used to measure depression was constructed from a series of questions relating to 
classical symptoms of depression—anxiety attacks; inability to sleep; inability to 
concentrate on job or other normal aspects of life. The index was used to assign to each 
individual a probability of having an episode of serious depression in the coming year. 
About 87% of respondents in the 18-64 age group were assigned a zero probability. We 
looked at the roughly 10 percent of the age group with a 90% probability of a major 
depressive episode in the coming year. The percent with a high probability of a major 
depression was somewhat higher in the U.S. than in Canada (9.7% versus 9%). Of that 
group we calculated the percent who consulted a health professional in the past 12 
months and then for those who received professional help we tabulated the type of 
professional consulted. The type of professional consulted is of interest. The percentage 
that was treated by a psychiatrist is significantly higher in the U.S. (26% in the U.S. 
versus 17% in Canada). However, the institutionalized population is absent from the 
survey. Differences in policy concerning deinstitutionalization may influence these 
results.  
      Table 10 presents data on the availability of Magnetic Resonance Imaging (MRI) 
and Computed Tomography (CT) Scanners in Canada and the U.S. and  also provides 
comparison with other OECD countries.  The gap between the U.S. and Canada is very 
large—32.0 per million vs 11.3 per million for CTs and 27.0 per million vs 5.5 per 
million for MRIs.  Note that it is difficult to make accurate comparisons across countries 
in some cases because of differences in the location of the equipment—hospitals or 
specialized facilities or exclusions of private facilities.  But for the U.S. and Canada this 
is not a problem.  (See the notes to the table.)  Again, as with the differentials in 
screening, the huge gap in equipment has the potential to create differentials in health 
outcomes. On the other hand, if such expensive equipment is inefficiently used in the 
10U.S. it could contribute to the higher expenditures in the U.S. but have little effect on 
health outcomes as some critics suggest. 
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              Waiting Times—How Long and How Important To Health Outcomes? 
     One useful side effect of the Chaoulli decision has been an increase in the collection 
of data on waiting time for various medical services in Canada. Waiting times are an 
emotionally charged issue in Canada and evidence on the number and lengths of 
significant waiting times have the potential of moving  the country closer to a “two-tier” 
system.  
      How widespread and how long are actual waiting times in Canada?  And how do 
these waiting times compare with the U.S.? Table 11 shows how times vary in Canada by 
type of source. The shortest waiting time shown was collected by Statistics Canada (but 
refers to two procedures combined). The longest estimates are those of the Fraser 
Institute. The medium estimates are those of the OECD. Although the methodology 
appears to be the same, one cannot be sure that they are so in all respects. For example, 
there could be differences in the voluntary component of scheduling which are not taken 
into account. 
    The issue of waiting time has not been prominent in the U.S. and is not routinely 
surveyed by the U.S. statistical agencies. The JCUSH data do not measure lengths of 
waiting spells but do present information on the significance of waiting to individuals in 
the two countries. The question is addressed as part of an inquiry about whether the 
respondent experienced unmet medical needs and if so, what the reason was for the 
unmet need. Among those ages 18-64, a somewhat higher percentage of Americans 
(14.4%)  than of Canadians (11.3%) reported experiencing one or more unmet health care 
needs in the year prior to the survey (Table 12). Among older people the percentages 
reporting unmet needs are about the same in the two countries. Those with an unmet need 
were then asked the reason for the unmet need ---had to wait too long or service not 
available; cost ( i.e. could not afford service); or a reason other than those two.  As Table 
12 shows, the wait too long/service not available reason dominates among the Canadians 
                                                 
4 In their study of the British health care system Aaron and Schwartz address the relatively low level of  
spending by the British on imaging machines, raising the question, “Sensible Savings or Foolish 
Frugality?” (pp.89).  
11who had an unmet need, while for U.S. residents cost was the major factor and wait too 
long was relatively minor. Other reasons were about equally important in both countries.  
    Table 13 provides some direct information about the length of the wait for services in 
Canada and in the U.S. For knee-replacement surgery the study cited in shows a median 
waiting time of 12 weeks in Canada versus 5 weeks in the U.S. (These figures include 
both the time it took  to see a specialist and the time elapsed between the specialist’s 
decision on surgery and the actual performance of the surgery.) The other comparison in 
Table 13 is based on a special survey of individuals funded by the Commonwealth 
Institute and carried out by the Canadian Institute for Health Information. (These figures 
give separately the times to go from an internist to a specialist and from the specialist’s 
surgery decision to the actual surgery). The waiting times are significantly greater in 
Canada.
5    
    Clearly “all the instruments agree”, waiting times are significantly longer in Canada 
than in the U.S..  But does the extra waiting time have an important effect on well being?  
Using the JCUSH data we cross-classified individuals in each country who reported 
having an unmet need by the reason for it and whether they reported suffering significant 
pain during the year (see Table 6 above). We found that among those who gave “wait too 
long or not available” as reasons, 33% of the Canadians said they had pain that limits 
their activities while 22% of the much smaller group of Americans who indicated that 
waiting time was a reason for an unmet need reported pain.  Among those who gave 
“cost” as the reason for the unmet need, 29% of Americans reported pain—37% of the 
smaller group of Canadians.  
    We also examined the effect of unmet needs on the Health Utility Measure (HUI) of 
health status and found that in Canada unmet needs reduced the HUI by 0.097 (compared 
to a mean of 0.898) when the individual cited waiting as a reason for unmet need 
(holding other variables constant in a multiple regression model; see Appendix Table2). 
The effect is much smaller and not significant for Americans.    
 
                                                 
5 Note that the Fraser Institute data in Table 11 for joint replacement surgery (for which knee replacement 
is a major component) indicate a much longer waiting time (30 weeks) than the study cited in Table 13.   
These differences could be attributed to differences in sampling as well as differences in concept. But both 
indicate long waits. 
12Evidence of Differential System Effectiveness  
    Based on our analysis of  JCUSH and of other large health interview surveys in 
Canada and the U.S. we find significant differences between the two countries in the use 
of early detection  testing (mammograms, pap tests, PSA tests and colonoscopies) and in 
the availability of medical imaging machines used for early detection  (MRIs and Ct 
Scans).  The US is a much greater user of testing and has many more units of imaging 
machines per capita. If these procedures and machines are impacting on health outcomes 
we should observe it in data on mortality rates for those who have cancer. Ideally on 
would want to know the results of broadly applicable studies of survival rates conducted 
under the same circumstances in both countries, but those are difficult to find. Table 14 
provides a very rough approximation of a cancer outcomes study.  
    Table 14 shows relevant data collected by cancer institutes in Canada and the U.S. on 
mortality rates and incidence rates for five types of cancer that could be  affected by early 
detection tests as well as by treatment efficacy. Note that the relevant comparison is 
between the ratios of the mortality rate to the incidence rate in the two countries. The 
lower this ratio, the lower is the death rate for those who have the disease (roughly 
speaking). Comparing the mortality rate with the incidence rate is important because high 
mortality taken alone may simply be the result of a high incidence of the cancer due to 
environmental, cultural or other such factors. As shown in Table 14, among women the 
age adjusted cancer incidence rate is higher in the United States than in Canada for all of 
the types of cancer shown and the mortality rates are somewhat higher in three of the four 
cancers. The ratio of mortality to incidence is somewhat lower in the U.S. for all cancers 
together and for three out of the four cancers shown (cervical cancer being the 
exception).  Among men the story is similar, but the ratio is lower in the U.S. for all 
cancers shown. Thus in terms of the detection and treatment of cancer, the performance 
of the U.S would appear to be somewhat better than Canada’s. 
Evidence on the Difference in the Income/Health Gradient 
   We turn now to  evidence on the claim that in Canada the relation between favorable 
health outcomes and income is minimal or is much less strong than in the U.S.  In other 
words we investigate whether the income/health gradient is steeper in the U.S. than in 
Canada. One of the benefits anticipated from a single payer system is a more equitable 
13distribution of health resources and health outcomes than would occur in a system where 
access partly depends on ability to pay.  
      Although numerous studies have examined the relation between income and health, 
not many have related inequality in income of individuals to inequality in their health 
status within a given country. Some studies have looked broadly at the relation between 
health and income-- historically; and across and within countries (Cutler, Deaton and 
Lleras-Muney.  Many studies simply look at variation in mean income across areas 
(countries, states) and relate it to observed measures of health status (Marmot 2002). 
Other across-location studies relate measures of inequality of income (variation across 
areas) to variation in the average level of health across areas (Ross et al., 2000).   
       Our interest, however, is in the correlation across individuals in their personal 
income and their personal health status, and in the comparison of this relationship in 
Canada and the U.S. The data demands of such a study are ordinarily difficult to meet. 
because of the difficulty of  assembling data for different countries with similar measures 
of both income and health status. Data on the personal incomes of individuals and 
households are collected in both Canada and the U.S, as are some measures of health 
status (typically self reported health status).  But the data on income are both measured 
and published in different formats making unbiased estimates in both countries difficult 
to execute. The main empirical problem in comparing gradients in the U.S. and Canada is 
that both the mean and relative variation of income is significantly greater in the U.S. 
And the crude techniques for measuring personal income variation have biased most 
existing estimates toward finding a steeper gradient in the U.S.   
  We utilize mainly JCUSH, which offers the best opportunity for measuring incomes in 
each country in the same way and thus derive unbiased estimates of the gradient in each 
country. Studies comparing gradients between countries have finessed the problem of 
non-comparable income distribution data by using a crude measure of income inequality 
(Decker and Remler, 2004).  We use the JCUSH data to illustrate the bias in the previous 
studies.  
   Tables 15-A and 15-B present evidence on the size of the income/health gradient in 
the U.S. and Canada, separately by age and for whites and the total population. For the 
younger group it is clear that except for one comparison (among whites for the poor or 
14fair measure of health status) there is a steeper gradient in the U.S. between the average 
of the health indicator for all those below the median vs all those above the median.   For 
example the average percent poor or fair drops by 9.8 percentage points for all Canadians 
while in the US the corresponding drop is 11.8 percentage points.  Similarly the average 
percent reporting very good or excellent health rises by 18.8 percentage points in Canada 
and by 23.7 percentage points in the U.S.   However, for the older group the results are 
not so clear cut.  In more than half the comparisons the gradients are steeper in Canada.  
     But all of the above and below the median comparisons in these tables are biased 
toward finding a steeper slope in the U.S.  This bias is revealed when one uses the 
relatively detailed income data in JCUSH to compute the mean income of those 
individuals with incomes above and below the median. (The means of those above and 
below the median are displayed in the tables.) Note that the ratio of mean income of those 
above the median to the mean income of those below median income in the U.S.  is 
significantly  greater for both the all person  comparisons and the white only 
comparisons.  For all persons the Canadian ratio is 3.27 and the U.S. ratio is 3.54, while 
for the white only comparison the Canadian ratio is 3.21 and the U.S. is 3.40. This means 
that the relative variance of income across persons is much greater in the U.S., and this 
would generate a larger spread in the measures of health status even if the gradient were 
the same in both countries.  By simply using above and below the median in each country 
we are in effect forcing a steeper gradient on the U.S. data.  
          Fortunately, the JCUSH data enable us to make comparisons using a        
continuous income variable that assigns a value to each individual. Thus the greater 
relative spread in the U.S. income data can be measured with some accuracy. The rate of 
change can be estimated as the partial regression coefficient of the income variable in 
separate multiple regression equations for Canada and the U.S. (using the health measure 
as the dependent variable) and the results for the two countries can be compared. The 
larger the coefficient (in absolute value), the steeper will be the gradient.  Tables 16 and 
17 show the results of our analysis.  With JCUSH we were able to do two analyses, one 
using the Health Utility Index (HUI) to measure health status (Table 16) and one using 
self reported poor/fair (Table 17). 
15    Table 16 shows the partial effect of income on the health utility index in three 
multiple regression models that hold different numbers of other variables constant.  
  Income, as Cutler, Deaton and Lleras-Muney (2005) note, itself is likely to be affected  
by health. It is also correlated with other variables that affect health status such as 
education and chronic conditions. We don’t expect to resolve these difficult    
problems of cause and effect. But we do the regression in stages so that changes in the 
effect of income on health can be observed when different variables are included in the 
regression.  Model 1 contains controls for demographic variables and education.  
Model II adds variables that measure health risks such as underweight, obesity, smoking 
currently or formerly, and a series of chronic conditions. Model III adds health access 
variables—unmet needs due to waiting, cost or other reasons, whether has a regular 
doctor and whether needed medicine but couldn’t afford it. Means of all the variables and 
full results for all the independent variables in the model III version 
With HUI as the dependent variable are provided in the Appendix.  
        Note that among the 18-64 year olds, the gradient in all three HUI regression models 
is actually steeper in Canada than in the U.S. (Table 16). And the same result holds when 
we use fair/poor to measure health status (Table 17).  For this measure of health status the 
Canadian coefficients are quite a bit steeper than those in the U.S.. The results are less 
consistent for the older age group. In the HUI regression results the gradient is weaker in 
Canada than in the U.S. and is not statistically significant. But the results with fair/poor 
as the health status measure again show steeper gradients for the older group in Canada.
6  
        Perhaps it should not be surprising to find that the gradient is alive and well in 
Canada despite the presence of a single payer system. It is difficult for any society to 
change traits that are health risks and that are usually strongly correlated with income. 
Nor does free access to medical care guarantee equal ability to navigate and use the 
health care system. 
  
Consumer Satisfaction 
                                                 
6 Income for retired individuals, however, can be unreliable because income from assets and imputed 
income from owned homes are a larger component of income but are not adequately reflected in the 
income measure.  
 
16Table  shows tabulations from two JCUSH questions, one dealing with how one rates 
the quality of care received and the other with overall satisfaction with health care 
services received in the past year.  Perhaps surprisingly, U.S. respondents quite 
significantly gave higher ratings to the quality of care received and were more satisfied 
with health care services received than were the Canadians.  
Concluding Comments 
      It is commonly supposed that a publicly funded single payer health care system will 
deliver better health outcomes, and distribute health resources more fairly than a multi-
payer system with a large private component.  Based on our analysis of health care 
measures in Canada and the U.S. we find a somewhat greater incidence of chronic health 
conditions in the U.S. combined with evidence of greater access to health treatments for 
these conditions. Health status is similar in both countries. But Canada has no more 
abolished the tendency for health status to improve with income than have other 
countries. Indeed, the health-income gradient is more prominent in Canada than it is in 
the U.S. The need to ration when care is delivered “free” ultimately leads to long waits or 
unavailable services and to unmet needs. In the U.S. costs are more often a source of 
unmet needs. But costs may be more easily overcome than the absence of services. When 
asked about satisfaction with health services and the ranking of the quality of services 
recently received, more U.S. residents than Canadians respond that they are fully satisfied 
and rank quality of care as excellent.  
        One important issue that we do not address concerns the large differential in per capita 
health care expenditures which are about twice as large in the U.S. Is the U.S. getting 
sufficient additional benefits to justify these greater expenditures and where should we 
cut back if cutbacks must be made? Alternatively, what would Canada have to spend to 
increase their technical capital and specialized medical personnel to match American 
levels or to eliminate the longer waiting times? And would it be worthwhile to them to do 
so? To answer these questions more research is needed along the lines of the recent study 
by Henry Aaron and William Schwartz (2005) that examines the British system in depth 
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20Table 1
Life Expectancy and Infant mortality in Canada, the U.S. and Selected 
OECD Countries (2003).    
Life Expectancy Infant 
Mortality 
(per 1000 live 
births) At birth At 65 years of age
  Male Female Male Female
U.S 74.8 80.1 16.8 19.8   6.8
    White 75.3 80.5 16.9 19.8   5.7
    Black 69.0 76.1 15.9 18.5 13.5
Canada 77.4 82.4 17.4 20.8   5.3
Denmark 75.1 79.9 15.5 18.6   4.4
France 75.9 82.9    17.1 
1)     21.4 
1)   4.0
Germany 75.7 81.4 16.1 19.6   4.2
Italy 76.8 82.5    16.6 
1)     20.6 
1)   3.9
Japan 78.4 85.3 18.0 23.0   3.0
Korea 73.9 80.8 15.1 19.0      5.3 
1)
Luxembourg 75.0 81.0 15.5 19.0   4.9
Sweden 77.9 82.5 17.0 20.3   3.1
U.K 76.2 80.7    16.1 
1)    19.1 
1)   5.3
1) Reported for 2002. 
Source: OECD Health Data 2007. CDC-NCHS, National Vital Statistics.
21Table 2
Birthweight Distributions (in %) 
a) and Birthweight-specific      
Infant Mortality (per 1000 live births)                        
in Canada and the United States











<1500  1.4  0.9 247.3 262.2
1500-1999  1.5  1.1 29.3 36.6
2000-2499  4.6  3.7 12.2 12.9
2500-2999 16.6 15.0 4.8 4.4
≥3000 75.9 78.9 2.1 2.0
Unknown 
b)  0.0  0.5 187.8 33.8
<2500  7.5  5.7 60.4 58.0
a) %s for birthweight distribution are of those with known birthweight.
b) % of total births.
Source: Michael S. Kramer, Fernando C. Barros, Kitaw Demissie, Shiliang Liu, 
John Kiely and K. S. Joseph. "Does reducing infant mortality depend on preventing 
low birthweight? An analysis of temporal trends in the Americas." Paediatric and 
Perinatal Epidemiology 2005,19:447–448, derived from Table 1 and Table 2. 
22Table 3
Prevalence of Obesity ( % with BMI of 
30 or more) in United States, Canada 
and Selected OECD Countries 
(2004/2005)
  Male Female
U.S 31.1 33.2
Canada     17.0 
1)     19.0 
1)
Denmark     11.0 
1)     11.8 
1)
France    9.8    9.3
Germany     14.4 
1)     12.8 
1)
Italy     17.0 
1)       9.7 
1)
Japan    2.8    3.2
Korea        3.7 
1)        3.3 
1)
Luxembourg   19.0   17.1
Sweden     9.8     9.9
U.K    22.7    23.2
 
1) Countries reporting data for 2005; all others 
reported for 2004.
Note: The Body Mass Index (BMI) is based on 
weight (kilograms) divided by height 
(meters)squared.
Source: OECD Health Data 2007.
23Table 4
Mortality Rates by Age Group in Canada and the United States and Percent of the U.S.-Canada 
Mortality Gap in Each Age group Due to Accidents/Homicides and to Heart Diseases
Female Male
Mortality due to 
all causes Gap     
(US-CA)
 










to all causes Gap     
(US-CA)






% of Gap  
due to 
diseases 
of heart US CA US CA
By age
20-24 47.3 32.1 15.2 64.5   3.9 138.0 82.4 55.6 84.4   4.3
25-29 54.5 33.3 21.2 51.9 10.4 135.6 79.8 55.8 74.4   7.3
30-34 72.0 43.6 28.4 32.4 13.4 143.2 89.7 53.5 60.0 13.8
35-39 109.3 66.7 42.6 32.2 20.0 193.8 120.9 72.9 42.8 17.4
40-44 174.5 97.5 77.0 23.0 18.6 289.5 172.0 117.5 27.6 23.1
45-49 262.5 172.3 90.2 18.8 28.2 444.4 269.8 174.6 19.6 27.2
50-54 372.7 273.6 99.1 13.1 38.7 657.0 428.7 228.3 12.9 30.4
55-59 562.7 424.7 138.0   6.7 38.4 917.3 678.4 238.9   6.7 38.9
60-64 893.6 683.1 210.5   4.8 40.7 1411.0 1130.2 280.8   3.1 45.4
65-69 1381.2 1075.6 305.6   1.6 41.6 2125.1 1766.7 358.4   4.7 49.6
Source: CDC/NCHS, National Vital Statistics System, Report LCWK1; Statistics Canada, Catalogue No. 84F0209, Mortality, 
Summary List of Causes, 2004.
24 
Table 5
Self Reported Health Status in Canada and the US: Results from Different Surveys
JCUSH Canada      
CCHS
U.S.        
NHIS
U.S.          
MEPS All Persons White Only
Canada U.S. Canada U.S. All White All White All White
    Ages 18-64 Ages 20-64 Ages 18-64
Self reported health status    
(% distribution)
  Poor   2.6   3.2   2.6   2.6   2.1   2.1   2.3   2.2   2.8   2.7
Fair   6.0   8.6   6.4   5.9   7.4   7.1   7.2   6.7   8.2   7.6
  Good 26.2 25.9 24.0 24.6 29.4 28.4 24.4 23.7 26.9 26.2
Very good 38.1 33.8 39.3 36.9 37.2 38.2 33.8 34.5 34.8 35.8
  Excellent 27.0 28.6 27.7 30.0 24.0 24.3 32.3 33.0 27.4 27.8
  Ages 65+
Self reported health status    
(% distribution)
  Poor   7.9   9.5   8.1   8.5   6.8   6.5   7.3   6.6   6.8   6.5
Fair 19.4 19.4 17.7 16.7 19.9 19.1 18.3 17.2 17.0 16.0
  Good 37.6 30.3 36.2 30.9 36.7 36.4 35.8 36.2 33.8 33.6
Very good 27.0 25.8 29.6 27.9 25.2 26.2 26.1 27.0 28.2 28.9
  Excellent   8.0 15.0   8.4 16.0 11.5 11.8 12.6 13.0 14.2 15.0
Source: Joint Canada/United States Survey of Health(JCUSH), Canadian Community Health Survey (CCHS), United States National 
Health Interview Survey (U.S. NHIS), and United States Medical Expenditure Panel Survey (U.S. MEPS): all in year 2003. 
25Table 6 
Other Indicators of Health Status in Canada and the U.S.
All Persons White Only
Canada U.S. Canada U.S.
Ages 18-64 
Health Utility Index(HUI)                         
    Mean score   
0.898 0.883 0.897 0.892
% with major depression 
1)   9.0   9.7   9.1   9.8
% reported pain that limits activities 11.0 11.9 11.2 10.6
Ages 65+
Health Utility Index(HUI)                         
    Mean score   
0.795 0.782 0.798 0.798
% with major depression 
1)   3.6   3.7   3.9   3.2
% reported pain that limits activities 20.3 20.7 20.6 18.7
1) Major depression refers to those with 90 percent probability of depression. This 
variable calculates the probability that the respondent would have been diagnosed as 
having experienced a major depressive episode in the past 12 months, if they had 
completed the Long-Form Composite International Diagnostic Interview (CIDI). The 
items used to measure depression are a subset of items from the CIDI that measure 
major depressive episode (MDE). The short-form of MDE used in the JCUSH was 
developed to operationalize the diagnosis of MDE.
Source: Joint Canada/United States Survey of Health.
26Table 7-A
Incidence and Treatment Status of Certain Health Conditions in Canada and the U.S., Ages 18-64
All Persons White Only

















1 Asthma   6.6 80.3   7.8 78.8     6.9 82.7   7.7 77.6
2 Arthritis excluding fibromyalgia 11.6 N.A. 12.5 N.A. 12.4 N.A. 13.1 N.A.
3 High blood pressure   8.8 84.1 13.1 88.3     9.1 83.2 12.5 87.3
4 Emphysema or related disease   0.5 53.0   1.3 73.1     0.6 53.0   1.4 69.4
5 Diagnosed with diabetes   3.2 ---   4.9 ---   3.1 ---   3.8 ---
Takes insulin --- 24.6 --- 28.8 --- 30.6 --- 24.7
Takes diabetic pills --- 63.4 --- 72.0 --- 58.4 --- 65.2
Takes insulin or pills --- 80.3 --- 83.9 --- 79.9 --- 79.9
6 Heart disease   2.4 67.2   2.6 69.6   2.7 69.4   2.4 73.2
7 Coronary heart disease   0.9 88.9   1.0 94.8   0.9 87.5   0.8 95.6
8 Angina   0.9 74.6   1.1 61.0   0.9 70.7   0.8 75.1










Incidence and Treatment Status of Certain Health Conditions in Canada and the U.S., Ages 65 and Over
All Persons White Only


















Asthma   7.1 82.5   6.6 91.6   7.1 82.8   6.2 91.7
Arthritis excluding fibromyalgia 39.4 N.A. 46.5 N.A. 39.6 N.A. 46.2 N.A.
High blood pressure 40.8 95.1 45.0 97.7 40.7 94.9 42.8 97.7
Emphysema or related disease   3.8 64.3   5.3 73.6   3.9 65.1   5.3 71.0
Diagnosed with diabetes 12.9 --- 16.3 --- 12.0 --- 14.8 ---
Takes insulin --- 17.5 --- 26.3 --- 14.9 --- 26.7
Takes diabetic pills --- 71.7 --- 74.0 --- 69.7 --- 73.2
Takes insulin or pills --- 80.4 --- 91.3 --- 76.0 --- 91.5
Heart disease 13.7 91.4 17.7 90.8 12.9 92.3 17.0 90.2
Coronary heart disease   4.9 90.5   6.8 96.3   5.3 90.9   6.9 95.4
Angina 10.3 73.0   5.8 77.7 10.2 74.9   5.5 77.1
Source: Joint Canada/United States Survey of Health
28Table 8
Preventive Care: Percentage of Relevant Population Group 







Mammogram for breast cancer,          
women ages 40-69
% Ever had mammogram 72.3 88.6 73.6 85.8
% Last had mammogram
  Less than 2 years ago 54.7 74.9 57.1 74.1
2 to less than 5 years ago 10.6   8.0 11.1   7.1
PAP smear for cervical cancer,             
women ages 20-69
% Ever had PAP test 88.2 96.2 89.9 96.5
% Last had a PAP test
  Less than 3 years ago 75.1 86.3 77.5 88.2
3 to less than 5 years ago   4.6   2.7   4.3   3.3
PSA test for prostate cancer,                
men ages 40-69
% Ever had PSA test 16.4 54.2
% Last had PSA test  
  Less than 3 years ago 15.2 49.5
3 to less than 5 years ago   0.7   2.2
Colonoscopy/Sigmoidoscopy (CorS) 
for colorectal cancers,                           
men ages 40-69
% Ever had CorS   4.6 29.0
% Last had CorS
Less than 2 years ago   1.9 16.7
2 to less than 5 years ago   1.3   7.9
Colonoscopy/Sigmoidoscopy (CorS) 
for colorectal cancers,                           
women ages 40-69 
% Ever had CorS   5.4 29.8
% Last had CorS  
Less than 2 years ago   2.0 16.4
2 to less than 5 years ago   1.6   8.2
Source: Joint Canada/United States Survey of Health, 2002-2003; Canadian 
Community Health Survey (CCHS), 2003; U.S.Medical Expenditure Panel Survey 
(MEPS), 2003.
29Table 9
Incidence and Type of Treatment of Those With Major Mental 
Depression, Ages 18-64
All Persons White Only
Canada U.S. Canada U.S.
 % with depression   9.0   9.7     9.1   9.8
% with depression who consulted a 
health professional
56.2 52.1 61.9 61.2
Type of professional (%) *
Family doctor or gen. practitioner 67.5 56.5  67.9 57.3
Psychiatrist 17.4 26.1  17.8 25.4
Psychologist 26.2 18.9  27.2 16.9
Nurse   5.0   4.8   5.2   3.3
Social worker or counsellor 18.5 15.0  17.9 15.2
Other professional   9.3   5.3   10.4   6.2
* Will not add to 100% because categories are not mutually exclusive.
Source: Joint Canada/United States Survey of Health.
30Table 10
Number of Computed Tomography (CT) Scanners per Million 
Population and Number of Magnetic Resonance Imaging (MRI) 
Scanners per Million Population in Selected OECD Countries
Number of CTs         
per Million Population
Number of MRIs         
per Million Population
Country (Year reported):
Japan (2002) 92.6 35.3
UNITED STATES (2004) 32.0 27.0
Korea (2003) 31.9   9.0
Austria (2003) 27.2 13.5
Italy (2003) 24.0 11.6
Switzerland (2003) 18.0 14.2
Greece (2002) 17.1   2.3
Denmark (2003) 14.5   9.1
Sweden (1999) 14.2   7.9
Germany (2002) 14.2   6.0
Finland (2003) 14.0 12.8
Spain (2003) 13.0   7.3
Czech Republic (2003) 12.6   2.4
New Zealand (2004) 12.1  ---
CANADA (2005) 11.3   5.5
Slovak Republic (2003)   8.7   2.0
France (2003)   8.4   2.8
Turkey (2003)   7.3  ---
UK (2004)   7.0   5.0
Sources: Canadian Institute for Health Information, Medical Imaging in Canada, 2005, 
pp. 55-56, derived from Figure 17 and Figure 18.
Notes:
a) In Canada, units located both in hospitals and in free-standing imaging facilities are 
included. Data is as of January 1, 2005.
b) In Japan, only units located in hospitals and general clinics are counted.
c) In Greece, CT scanners/MRI units from military hospitals and private diagnostic centres 
are also included.
d) In the UK, raw numbers of CT/MRI units for England and Wales have been increased by 
the OECD Secretariat to provide an estimate for the UK. The private sector is not included in 
the data.
e) In the U.S., units located both in hospitals and in non-hospital sites are included. IMV was 
used as the data source, because it counts the number of CTs, whereas OECD figures are a 
count of the number of hospitals that report having at least one scanner.
f) In Germany, data on medical technology includes equipment installed in acute care 
hospitals and in prevention and rehabilitation homes. The table comprises CT units as well 
as PET units.
31Table 11
 Waiting Times in Canada for Non-Emergency 
Surgery: Estimates from Different Data Sources
Median Weeks Waiting
Data Source and Procedure:
Statistics Canada 
1
Joint Replacement and 
Cataract Surgery   8
OECD 
2




Joint Replacement    30
Cataract Surgery 12
1  “Access to Health Care Services in Canada”, January to 
December 2005, Statistics Canada.
2 Siciliani & Hurst, “Explaining Waiting Times Variations for Elective 
Surgery across OECD Countries”, OECD HEALTH WORKING 
PAPERS (2003) #7.
3 Nadeem Esmail & Michael Walker, “Waiting Your Turn 16th 
Edition: Hospital Waiting Lists in Canada”, The Fraser Institute, 
2006.
Note: The data were derived from different underlying populations. 
Statistics Canada bases its numbers on the responses of individuals 
to questions about their waiting time experiences. The information is 
obtained as a by-product of their household survey. The OECD 
utilizes administrative data collected by various provincial 
governmental agencies.  The Fraser Institute generates its own 
survey of specialist physicians and asks them to estimate patient 
waiting time from the date the surgery was scheduled to the date the 
surgery actually took place. All the estimates shown above also refer 
to that same period—weeks elapsed between the date scheduled by 
the specialist and the actual surgery.  Information (not shown) is 
also collected on the waiting time between referral to a specialist 
and the actual meeting with the specialist.  
32Table 12
Percent of Those with Self Reported Unmet Health Need and Reason 
for Unmet Need
Ages 18-64 Ages 65+
Canada U.S. Canada U.S.
% with unmet need 11.3 14.4   7.4   6.4
    Reason for unmet need (%) :
  Wait too long or not available 56.3 13.2   51.9 24.6
Cost   8.6 54.7   2.2 35.9
Other reasons 36.6 33.2 45.9 42.6
* Categories with reasons are not mutually exclusive and therefore will not add to a 
hundred.
Source: Joint Canada/United States Survey of Health.
33Table 13
 Differences in waiting time to see a specialist or 
have elective surgery: Canada vs. the U.S. 
1)
 Canada   U.S
% waited more than four weeks to:
Consult a specialist 57 23
Have elective surgery   82 42
Median waiting time for                         





    5
1) Waiting for Health care in Canada: What we know and What 
We Don’t Know, Canadian Institute for Health Information (March, 
2007) in Canada. 
2) Peter C. Coyte, et. al, “Waiting Times for Knee-Replacement 
Surgery in the United States and Ontario” The New England 
Journal of Medicine, Vol. 331:1068-1071,October 20, 1994, 
Number 16.
34Table 14
Incidence Rates and Mortality Rates of Selected Types of Cancer                                             
Average of 2001-2003
Female Male


























All Cancers 414.5 162.5 0.39 349.8 148.6 0.42 562.1 239.4 0.43 464.4 219.7 0.47
Lung 54.8 41.3 0.75 45.0 35.0 0.78 88.9 73.5 0.83 73.2 63.9 0.87
Breast 125.3 25.6 0.20 99.0 24.5 0.25 --- --- --- --- --- ---
Prostate --- --- --- --- --- --- 162.0 27.9 0.17 124.7 25.2 0.20
Colorectal 45.6 16.5 0.36 42.8 17.5 0.41 62.6 23.7 0.38 62.8 27.2 0.43
Cervix 8.6 2.6 0.30 7.9 2.0 0.25 --- --- --- --- --- ---
a) Incidence and mortality rates are all age-adjusted.
b) Ratio of mortality rate to incidence rate.
Source: United States Cancer Statistics, National Program of Cancer Registries, Centers for Disease Control; Canadian Cancer Society/national 
Cancer Institute of Canada.
35Table 15-A
Income and Self-reported Health Status Differences, Ages 18-64     
(US dollars *)




Very good or 
excellent
Excellent
All Canadian   
<median 25.7 14.7 54.2 21.2
  ≥ median 81.3 4.9 73.0 30.4
All US
<median 28.9 17.6 50.2 21.2
  ≥ median 96.7   5.8 73.9 34.5
White Canadian
<median 25.9 15.6 55.9 22.4
≥ median 81.6   5.1 73.6 30.7
White US
<median 30.6 12.8 54.6 23.0
≥ median 98.7   5.3 75.6 34.8
* Canadian dollars converted to US dollars using purchasing power parity. 
Source: Joint Canada/United States Survey of Health.
36Table 15-B
Income and Self-reported Health Status Differences,             
Ages 65 and Over                                           
(US dollars *)







All Canadian   
<median 21.9 30.9 30.2   5.8
  ≥ median 71.7 17.2 54.2 19.1
All US
<median 24.9 34.2 36.0 11.7
  ≥ median 88.3 15.3 57.1 23.8
White Canadian
<median 22.0 29.9 33.1   6.6
≥ median 70.7 14.8 57.5 17.1
White US  
<median 26.0 29.8 38.1 12.5
≥ median 88.4 15.9 56.9 23.7
* Canadian dollars converted to US dollars using purchasing power parity. 
Source: Joint Canada/United States Survey of Health.
37Table 16
Effect of Income on Health Utility Index (HUI), JCUSH 
Canada U.S.




















Partial effect of income 
(000's)
0.0009 *** 0.0006 *** 0.0005 *** 0.0008 *** 0.0005 *** 0.0004 ***
Adj. R-Square 0.0687 0.2396 0.2749 0.0995 0.2818 0.3143
Mean of dependent 
variable
0.8978 0.8840
Sample size 2663 3797
Ages 65+
Partial effect of income 
(000's)
0.0005 0.0003 0.0003 0.0008 *** 0.0006 ** 0.0005
Adj. R-Square 0.0677 0.2098 0.2240 0.1165 0.2564 0.2826
Mean of dependent 
variable
0.7961 0.7830
Sample size 684 1017
Note: Complete regression results are shown in the Appendix for Model III (mean characteristics and variable 
coefficients). The demographic variables in Model I include sex, age group, education, whether nonwhite, 
whether immigrant, whether married and whether lives alone. Model II adds whether obese and other weight 
related variables, current and former smoking, incidence of various chronic diseases. Model III adds unmet 
needs and whether has regular doctor. Starred figures denote statistical significance at the following levels: 
*10%; ** 5%; ***1%.
Source: Joint Canada/United States Survey of Health (JCUSH) microdata file.
38*
Table 17
Effect of Income on Whether Reported Poor/Fair Health Status, JCUSH
Canada U.S.




















Partial effect of income 
(000's)
-0.0013 *** -0.0008 *** -0.0008 *** -0.0009 *** -0.0004 ** -0.0003 **
Adj. R-Square 0.0623 0.2082 0.2203 0.0929 0.2437 0.2589
Mean of dependent 
variable
0.0854 0.1163
Sample size 2710 3870
Ages 65+
Partial effect of income 
(000's)
-0.0019 *** -0.0014 * -0.0014 ** -0.0017 *** -0.0011 ** -0.0009 *
Adj. R-Square 0.0432 0.2300 0.232. 0.0831 0.2328 0.2407
Mean of dependent 
variable
0.2725 0.2860
Sample size 732 1090
Note: The demographic variables in Model I include sex, age group, education, whether nonwhite, whether 
immigrant, whether married and whether lives alone. Model II adds whether obese and other weight related 
variables, current and former smoking, incidence of various chronic diseases. Model III adds unmet needs 
and whether has regular doctor. Starred figures denote statistical significance at the following levels: *10%; ** 
5%; ***1%. (The regression specification is the same as that for the HUI regression detailed in the appendix. 
Regression results are available from the authors.)
Source: Joint Canada/United States Survey of Health (JCUSH) microdata file.
39Table 18
Quality and Satisfaction with Health Care Services
Ages 18-64 Ages 65+
Canada U.S. Canada U.S.
Rate the quality of health care received
Excellent 37.7 40.4 45.8 49.6
Good 46.7 47.5 43.8 41.8
Fair 12.9 10.0   8.3   6.6
Poor   2.8   2.1   2.1   2.1
Satisfaction with health care services
  Very satisfied 41.5 51.3 55.4 63.8
Somewhat satisfied 44.8 38.2 35.4 28.8
Neither satisfied nor dissatisfied   5.3   3.7   3.1   2.2
Somewhat or very dissatisfied   8.5   6.8   6.1   5.3




Means of Characteristics Use in HUI Regressions *
Ages 18-64 Ages 65+
Canada U.S. Canada U.S.
Household income (in thousands) 52.459 54.506 26.250 27.607
Household income missing (0,1) 0.132 0.183 0.223 0.329
Female (0,1) 0.499 0.512 0.559 0.574
Age groups:
 18-29  (0,1) 0.259 0.237 --- ---
 30-44  (0,1) 0.363 0.388 --- ---
 45-64  (0,1) 0.378 0.375 --- ---
 65-74  (0,1) --- --- 0.594 0.589
Less than high school (0,1) 0.145 0.095 0.452 0.207
High school graduate (0,1) 0.318 0.371 0.266 0.387
Attended community college or vocation school (0,1) 0.231 0.142 0.138 0.134
Attended university or college (0,1) 0.307 0.392 0.144 0.272
Non-white (0,1) 0.187 0.264 0.131 0.157
Immigrant (0,1) 0.186 0.171 0.264 0.106
Married (0,1) 0.662 0.644 0.615 0.606
Live alone (0,1) 0.115 0.203 0.286 0.332
Underweight (0,1) 0.028 0.022 0.024 0.020
Overweight (0,1) 0.320 0.321 0.384 0.359
Obese (0,1) 0.151 0.201 0.146 0.203
Body Mass Index missing (0,1) 0.035 0.039 0.026 0.035
Daily smoker (0,1) 0.203 0.184 0.102 0.068
Former daily smokers (0,1) 0.307 0.237 0.413 0.439
Has asthma (0,1) 0.066 0.077 0.069 0.060
Has arthritis (excluding fibromyalgia) (0,1) 0.116 0.123 0.394 0.459
Has high blood pressure (0,1) 0.087 0.130 0.405 0.452
Has emphysema (0,1) 0.005 0.012 0.041 0.044
Has diabetes (0,1) 0.032 0.048 0.127 0.157
Has heart disease (0,1) 0.024 0.023 0.133 0.167
Has coronary heart disease (0,1) 0.008 0.008 0.053 0.063
Has angina (0,1) 0.009 0.011 0.101 0.050
Has major depression (0,1) 0.089 0.096 0.033 0.033
Has regular medical doctor (0,1) 0.826 0.771 0.964 0.929
Needed medicines but could not afford it (0,1) 0.055 0.100 0.015 0.079
Unmet health need due to:
  Long wait or not available (0,1) 0.063 0.018 0.036 0.017
 Cost  (0,1) 0.009 0.077 0.001 0.022
  Other reasons (0,1) 0.042 0.046 0.032 0.025
* All variables are weighted.
Source: JCUSH microdata file.
41Appendix Table 2
Determinants of Health Status As Measured By Health Utility Index (HUI):      
Partial Regression Coefficients
Ages 18-64 Ages 65+
Canada U.S Canada U.S
Coef. t-stat Coef. t-stat Coef. t-stat Coef. t-stat
Intercept 0.933 65.19 0.931 77.18 0.728 11.55 0.746 19.15
Household income (in thousands) 0.000 4.79 0.000 5.06 0.000 0.62 0.000 1.59
Household income missing (0,1) 0.012 1.11 0.019 2.26 0.008 0.31 0.014 0.73
Female (0,1) 0.001 0.23 0.006 1.04 0.001 0.05 0.032 1.88
Age groups:
 18-29  (0,1) 0.018 2.17 0.010 1.29
 45-64  (0,1) 0.002 0.31 -0.020 -3.12
 65-74  (0,1)  0.082 4.29 0.061 3.96
Less than high school (0,1) -0.036 -3.80 -0.058 -5.86 -0.037 -1.65 -0.087 -4.27
Attended comm. col./voc. (0,1) 0.000 0.02 0.000 0.03 -0.007 -0.24 0.010 0.44
Attended univ. col. (0,1) 0.008 1.01 0.018 2.70 0.020 0.68 0.038 2.01
Non-white (0,1) -0.001 -0.11 -0.002 -0.33 -0.035 -1.28 0.004 0.18
Immigrant (0,1) -0.015 -1.72 0.003 0.39 -0.053 -2.51 0.003 0.12
Married (0,1) 0.023 2.85 0.009 1.37 0.073 2.49 0.073 3.56
Live alone (0,1) -0.009 -0.77 -0.004 -0.51 0.105 3.40 0.074 3.72
Underweight (0,1) -0.029 -1.58 -0.027 -1.44 0.038 0.63 -0.164 -3.10
Overweight (0,1) -0.013 -1.81 -0.007 -1.06 0.000 -0.02 0.047 2.71
Obese (0,1) -0.013 -1.46 -0.020 -2.57 -0.020 -0.71 -0.019 -0.90
Body Mass Index missing (0,1) 0.011 0.66 -0.004 -0.29 -0.009 -0.15 -0.056 -1.38
Daily smoker (0,1) -0.022 -2.64 -0.013 -1.72 -0.052 -1.63 -0.004 -0.12
Former daily smokers (0,1) -0.009 -1.28 -0.016 -2.37 -0.006 -0.28 -0.001 -0.05
Has asthma (0,1) -0.051 -4.18 -0.030 -2.98 -0.044 -1.20 -0.006 -0.19
Has arthritis (0,1) -0.115 -11.77 -0.112 -12.74 -0.116 -6.14 -0.113 -7.38
Has high blood pressure (0,1) -0.030 -2.71 -0.021 -2.35 0.002 0.11 -0.013 -0.82
Has emphysema (0,1) -0.030 -0.68 -0.106 -4.28 -0.073 -1.56 -0.045 -1.22
Has diabetes (0,1) -0.012 -0.72 -0.046 -3.51 -0.060 -2.10 -0.099 -4.81
Has heart disease (0,1) -0.021 -0.94 -0.040 -1.93 -0.012 -0.36 -0.068 -3.02
Has coronary heart disease (0,1) -0.021 -0.58 -0.063 -1.84 0.046 0.94 -0.060 -1.79
Has angina (0,1) -0.081 -2.36 -0.055 -1.95 -0.168 -4.95 0.008 0.23
Has major depression (0,1) -0.137 -12.58 -0.151 -15.86 -0.183 -3.50 -0.190 -4.61
Has regular medical doctor (0,1) -0.019 -2.34 -0.010 -1.50 0.070 1.45 0.006 0.22
Needed med. couldn't afford (0,1) -0.076 -5.53 -0.081 -7.94 -0.042 -0.56 -0.059 -2.01
Unmet health need due to:
  Long wait or not available (0,1) -0.097 -7.89 -0.028 -1.38 -0.068 -1.38 -0.025 -0.45
 Cost  (0,1) -0.043 -1.37 -0.058 -5.20 -0.438 -1.12 -0.170 -3.24
  Other reasons (0,1) -0.079 -5.25 -0.089 -6.88 -0.178 -3.37 -0.204 -4.32
Adj. R-Square 0.2749 0.3143 0.1042 0.2826
Dependent mean 0.8978 0.8840 0.2240 0.7830
Sample size 2663 3797 684   1017
* Regressions are weighted.
Source: JCUSH microdata file.
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